Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study.

Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study.

Item
http://www.wikidata.org/entity/Q34781913
CCR5 antagonism in HIV infection: current concepts and future opportunitiesEfavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsHIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry.CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells.Five-year safety evaluation of maraviroc in HIV-1-infected treatment-experienced patients.Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropismEffect of Zhen Qi Fu Zheng granules on the bone marrow depression model induced by Zidorf.Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States
P2860

Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study.

Item
http://www.wikidata.org/entity/Q34781913
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Antiviral activity and safety ...... the ASCENT (CCR102881) study.
@ast
Antiviral activity and safety ...... the ASCENT (CCR102881) study.
@en
Antiviral activity and safety ...... the ASCENT (CCR102881) study.
@nl
type
label
Antiviral activity and safety ...... the ASCENT (CCR102881) study.
@ast
Antiviral activity and safety ...... the ASCENT (CCR102881) study.
@en
Antiviral activity and safety ...... the ASCENT (CCR102881) study.
@nl
prefLabel
Antiviral activity and safety ...... the ASCENT (CCR102881) study.
@ast
Antiviral activity and safety ...... the ASCENT (CCR102881) study.
@en
Antiviral activity and safety ...... the ASCENT (CCR102881) study.
@nl
P1433
P1476
P2093
P304
P31
P433
P478
P50
P577
P698
P1433
P1476
Antiviral activity and safety ...... : the ASCENT (CCR102881) study
@en
P2093
P304
P31
P433
P478
P50
P577
P698